Valtoco is the first nasal spray approved by the Food and Drug Administration as a rescue treatment for people with epilepsy age 6 years old and older.
Gayle A. Brazeau discusses how pharmacy education is shaping the next generation of pharmacists who will provide outstanding patient care in community-based pharmacies and clinical healthcare teams.